Lilli Gordon – Trademark Portfolio
Entity Type: 01
Lilli Gordon holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 5 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include FIRST AID BEAUTY. The owner is based in Newton, MA.
10 Graycliff Road
Newton, MA 02459
Showing of trademarks Trademarks
Trademark Classifications
Lilli Gordon's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Lilli Gordon have?
Lilli Gordon has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned.
What trademark classes does Lilli Gordon file in?
Lilli Gordon files trademarks across 5 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 25 (Clothing), Class 44 (Medical Services). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Lilli Gordon's most well-known trademarks?
Lilli Gordon's registered trademark portfolio includes well-known marks such as FIRST AID BEAUTY. These are among 2 currently registered trademarks in the portfolio.
What is Lilli Gordon's trademark registration success rate?
Lilli Gordon has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.